Geraniol-d6 (Major)
CAT:
804-HY-W782079-02
Size:
5 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

Geraniol-d6 (Major)
- CAS Number: 1660976-93-1
- UNSPSC Description: Geraniol-d6 (Major) is the deuterated labeled Geraniol (Major). Geraniol is an olefin terpene with oral activity. Geraniol inhibits cell proliferation and promotes apoptosis. Geraniol has antibacterial, antifungal, antioxidant, anti-inflammatory and antitumor activities. Geraniol can be used to study diabetes[1][2][3][4][5].
- Target Antigen: Apoptosis; Bacterial; Fungal
- Type: Isotope-Labeled Compounds
- Related Pathways: Anti-infection;Apoptosis
- Field of Research: Cancer; Infection; Metabolic Disease; Inflammation/Immunology
- Purity: 95.25
- Solubility: DMSO : 100 mg/mL (ultrasonic;warming)
- Smiles: OC/C([2H])=C(C([2H])(C/C=C(C)\C)[2H])\C([2H])([2H])[2H]
- Molecular Weight: 160.29
- References & Citations: [1]Bard M, et al. Geraniol interferes with membrane functions in strains of Candida and Saccharomyces. Lipids. 1988 Jun;23(6):534-8. |[2]Kim SH, et al. Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways. Biochem Biophys Res Commun. 2011 Apr 1;407(1):129-34. |[3]Babukumar S, et al. Geraniol, a natural monoterpene, ameliorates hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Pharm Biol. 2017 Dec;55(1):1442-1449. |[4]Hosseini SM, et al. Geraniol attenuates oxidative stress, bioaccumulation, serological and histopathological changes during aluminum chloride-hepatopancreatic toxicity in male Wistar rats. Environ Sci Pollut Res Int. 2020 Jun;27(16):20076-20089. |[5]Pereira Fde O, et al. Antifungal activity of geraniol and citronellol, two monoterpenes alcohols, against Trichophyton rubrum involves inhibition of ergosterol biosynthesis. Pharm Biol. 2015 Feb;53(2):228-34.
- Shipping Conditions: Room Temperature
- Storage Conditions: 4°C (Powder, protect from light)
- Clinical Information: No Development Reported